Clinical trial
A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Controlled Trial Comparing Low Molecular Weight Heparin to Acetylsalicylic Acid in Orthopedic Trauma Patients
NCT02774265 is registered in ClinicalTrials.gov with University of Maryland, Baltimore as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Different Approach to Preventing Thrombosis (ADAPT): A Randomized Controlled Trial Comparing Low Molecular Weight Heparin to Acetylsalicylic Acid in Orthopedic Trauma Patients
- Lead sponsor
- University of Maryland, Baltimore
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2016
- Completion date
- September 30, 2017
- Enrollment
- 329 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.